We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How the MHRA makes decisions on whether a borderline product is a medical device and which risk class should apply.
How a marketing authorisation holder should report a defect with a veterinary medicine.
Things to consider when buying and using products.
Things to consider when buying or using cosmetics.
Papers from the Office for Product Safety and Standards.
Evaluations made by the Rapid Review Panel (RRP) on submitted products.
Change to the information provided on adverse events for Profender Modified-release Tablets, Profender Spot-on Solution and Profender Multi-dose Spot-on Solution in the SPC.
The value of UK imports and exports of goods grouped by product. Goods are attributed to the activity of which they are the principal products.
The value of UK imports and exports of goods grouped by product. Goods are attributed to the activity of which they are the principal products
Information and resources.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).